President's Message
News Release
October 06, 2021
|
Updated President's Message and Corporate Profile
July 27, 2021
|
Press Release
Grifols and OrphanPacific start commercializing Lynspad™ [alpha-1 proteinase inhibitor] to treat alpha-1 antitrypsin deficiency
February 22, 2021
|
[IPM(Innovative Pharma Model) Introduction Video] CMIC Group Released "Creative Service to Support Drug Development Journey in Japan" Video
January 22, 2021
|
Press Release
Announcement of Japan’s regulator approves Grifols’ Lynspad™ [alpha1-proteinase inhibitor] for the treatment of alpha-1 antitrypsin deficiency
January 22, 2021
|
Press Release
OrphanPacific, Inc. Receives Manufacturing and Marketing Approval of
ORLADEYO Capsules 150mg for Suppression of HAE Attacks in Japan
We associate with the activities of Rare Disease Day JAPAN and support activities.
